Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Despite the earnings beat, Intel's guidance for the first quarter of 2025 fell short of expectations. The company forecasts revenue between $11.7 billion and $12.7 billion, below the analyst consensus ...
Investing.com -- Shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) tumbled 6% today following the company's announcement that it has suspended its quarterly dividend. The move comes as part of ...